Howard Safir's most recent trade in Citius Pharmaceuticals Inc was a trade of 75,000 Options to Purchase Common Stock done . Disclosure was reported to the exchange on Oct. 4, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Citius Pharma Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharma Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharma Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 15,000 | 15,000 | - | - | Options to Purchase Common Stock | |
| Verint Systems Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2021 | 4,178 | 30,838 (0%) | 0% | 0 | Common Stock |